Page last updated: 2024-10-29

avapro and Adrenal Cortex Cancer

avapro has been researched along with Adrenal Cortex Cancer in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vanderriele, PE1
Caroccia, B1
Seccia, TM1
Piazza, M1
Lenzini, L1
Torresan, F1
Iacobone, M1
Unger, T1
Rossi, GP1

Other Studies

1 other study available for avapro and Adrenal Cortex Cancer

ArticleYear
The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
    Clinical science (London, England : 1979), 2018, 03-30, Volume: 132, Issue:6

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II Type 1 Receptor Blocke

2018